Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OligoG in Cystic Fibrosis
NCT03698448Phase 3Withdrawn
- Sponsor
- AlgiPharma
- Start
- Sep 2021
- Primary completion
- Oct 2022
- Modality
- Oligosaccharide
- Countries
- 1
01
Overview
A Phase 3 trial of OligoG in cystic fibrosis (CF), sponsored by AlgiPharma. Planned start Sep 2021; status: withdrawn.
02
Drugs
OligoG
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT03698448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03698448.